These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 33314369

  • 1. Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with 18 F-FDG PET-CT values.
    Wang Z, Huang K, Yang X, Shen K, Yang L, Ruan R, Shi X, Wang M, Zhu G, Yang M, Zhang C, Lv S, Yang H, Fan X, Liu S.
    Brain Pathol; 2021 Mar; 31(2):346-364. PubMed ID: 33314369
    [Abstract] [Full Text] [Related]

  • 2. Downregulated formyl peptide receptor 2 expression in the epileptogenic foci of patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Huang K, Wang Z, He Z, Li Y, Li S, Shen K, Zhu G, Liu Z, Lv S, Zhang C, Yang H, Yang X, Liu S.
    Immun Inflamm Dis; 2022 Nov; 10(11):e706. PubMed ID: 36301030
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Sun FJ, Zhang CQ, Chen X, Wei YJ, Li S, Liu SY, Zang ZL, He JJ, Guo W, Yang H.
    J Neuroinflammation; 2016 Apr 19; 13(1):85. PubMed ID: 27095555
    [Abstract] [Full Text] [Related]

  • 4. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Yue J, Zhang C, Shi X, Wei Y, Liu L, Liu S, Yang H.
    Brain Dev; 2019 Nov 19; 41(10):829-838. PubMed ID: 31495513
    [Abstract] [Full Text] [Related]

  • 5. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
    Talos DM, Sun H, Kosaras B, Joseph A, Folkerth RD, Poduri A, Madsen JR, Black PM, Jensen FE.
    Ann Neurol; 2012 Apr 19; 71(4):539-51. PubMed ID: 22447678
    [Abstract] [Full Text] [Related]

  • 6. Altered expression of the Plexin-B2 system in tuberous sclerosis complex and focal cortical dysplasia IIb lesions.
    Dai L, Huang J, Shen KF, Yang XL, Zhu G, Zhang L, Wang ZK, Liu SY, Liao X, Xu SL, Yang H, Li XY, Zhang CQ.
    Histol Histopathol; 2024 Sep 19; 39(9):1179-1195. PubMed ID: 38293776
    [Abstract] [Full Text] [Related]

  • 7. A distinct microRNA expression profile is associated with α[11C]-methyl-L-tryptophan (AMT) PET uptake in epileptogenic cortical tubers resected from patients with tuberous sclerosis complex.
    Bagla S, Cukovic D, Asano E, Sood S, Luat A, Chugani HT, Chugani DC, Dombkowski AA.
    Neurobiol Dis; 2018 Jan 19; 109(Pt A):76-87. PubMed ID: 28993242
    [Abstract] [Full Text] [Related]

  • 8. Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.
    Scholl T, Mühlebner A, Ricken G, Gruber V, Fabing A, Samueli S, Gröppel G, Dorfer C, Czech T, Hainfellner JA, Prabowo AS, Reinten RJ, Hoogendijk L, Anink JJ, Aronica E, Feucht M.
    Brain Pathol; 2017 Nov 19; 27(6):770-780. PubMed ID: 27750396
    [Abstract] [Full Text] [Related]

  • 9. Expression of TRPV1 in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
    Shu HF, Yu SX, Zhang CQ, Liu SY, Wu KF, Zang ZL, Yang H, Zhou SW, Yin Q.
    Brain Dev; 2013 Mar 19; 35(3):252-60. PubMed ID: 22647236
    [Abstract] [Full Text] [Related]

  • 10. Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Li S, Yu S, Zhang C, Shu H, Liu S, An N, Yang M, Yin Q, Yang H.
    Brain Res; 2012 May 09; 1453():46-55. PubMed ID: 22459050
    [Abstract] [Full Text] [Related]

  • 11. Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence.
    Arena A, Zimmer TS, van Scheppingen J, Korotkov A, Anink JJ, Mühlebner A, Jansen FE, van Hecke W, Spliet WG, van Rijen PC, Vezzani A, Baayen JC, Idema S, Iyer AM, Perluigi M, Mills JD, van Vliet EA, Aronica E.
    Brain Pathol; 2019 May 09; 29(3):351-365. PubMed ID: 30303592
    [Abstract] [Full Text] [Related]

  • 12. Characteristic expression of p57/Kip2 in balloon cells in focal cortical dysplasia.
    Kimura T, Kitaura H, Masuda H, Kameyama S, Saito Y, Sugai K, Otsuki T, Nakazawa A, Morota N, Yamamoto T, Iida K, Nakagawa M, Mizuno T, Takahashi H, Kakita A.
    Neuropathology; 2015 Oct 09; 35(5):401-9. PubMed ID: 25950494
    [Abstract] [Full Text] [Related]

  • 13. Predictive model for epileptogenic tubers from all tubers in patients with tuberous sclerosis complex based on 18F-FDG PET: an 8-year single-centre study.
    Wang Z, Li Y, He Z, Li S, Huang K, Shi X, Sun X, Ruan R, Cui C, Wang R, Wang L, Lv S, Zhang C, Liu Z, Yang H, Yang X, Liu S.
    BMC Med; 2023 Dec 18; 21(1):500. PubMed ID: 38110931
    [Abstract] [Full Text] [Related]

  • 14. Elevated Expression of TRPC4 in Cortical Lesions of Focal Cortical Dysplasia II and Tuberous Sclerosis Complex.
    Wang LK, Chen X, Zhang CQ, Liang C, Wei YJ, Yue J, Liu SY, Yang H.
    J Mol Neurosci; 2017 Jun 18; 62(2):222-231. PubMed ID: 28455787
    [Abstract] [Full Text] [Related]

  • 15. Type IIB focal cortical dysplasia with balloon cells in medial temporal lobe epilepsy: Clinical, neuroimaging, and histopathological findings.
    Mao C, Jin L, Dou W, Lu Q, Zhou L, Ren H, Zhao Y, Feng F, Guo Y, Gao J.
    Epilepsy Res; 2019 Nov 18; 157():106189. PubMed ID: 31472401
    [Abstract] [Full Text] [Related]

  • 16. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
    Shu HF, Zhang CQ, Yin Q, An N, Liu SY, Yang H.
    J Neuropathol Exp Neurol; 2010 Aug 18; 69(8):838-49. PubMed ID: 20613633
    [Abstract] [Full Text] [Related]

  • 17. Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex.
    Guo W, Zhang CQ, Shu HF, Yang MH, Yin Q, Yang H.
    J Mol Neurosci; 2013 May 18; 50(1):7-13. PubMed ID: 22752548
    [Abstract] [Full Text] [Related]

  • 18. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
    Nguyen LH, Mahadeo T, Bordey A.
    J Neurosci; 2019 Apr 03; 39(14):2762-2773. PubMed ID: 30700531
    [Abstract] [Full Text] [Related]

  • 19. FDG-PET/MRI coregistration and diffusion-tensor imaging distinguish epileptogenic tubers and cortex in patients with tuberous sclerosis complex: a preliminary report.
    Chandra PS, Salamon N, Huang J, Wu JY, Koh S, Vinters HV, Mathern GW.
    Epilepsia; 2006 Sep 03; 47(9):1543-9. PubMed ID: 16981871
    [Abstract] [Full Text] [Related]

  • 20. Infantile tauopathies: Hemimegalencephaly; tuberous sclerosis complex; focal cortical dysplasia 2; ganglioglioma.
    Sarnat HB, Flores-Sarnat L.
    Brain Dev; 2015 Jun 03; 37(6):553-62. PubMed ID: 25451314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.